Mark L. Smith

Modified Tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications

Mark L. Smith, John A. Lindbo, Stephan Dillard-Telm et al. · Virology · 2006 · 160 citations

Vaccination, Vaccine Development, Protein Antigens +10

Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form

Mark L. Smith, Hugh S. Mason, Michael L. Shuler · Biotechnology and Bioengineering · 2002 · 98 citations

TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models

Alison A. McCormick, Tina A. Corbo, Sherri Wykoff-Clary et al. · Vaccine · 2006 · 79 citations

Vaccination, Tumor Protection, Tumor Immunology +12

Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes

Kenneth E. Palmer, Ann L. Benko, Sarah A. Doucette et al. · Vaccine · 2006 · 76 citations

Vaccination, Molecular Virology, Human Papillomavirus Vaccines +8

Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies

Mark L. Smith, Lizabeth Richter, Charles J. Arntzen et al. · Vaccine · 2003 · 48 citations

Vaccination, Structural Characterization, Viral Hepatitis +9